GelSana Therapeutics
PrivateLast Round
Seed Round
Mar 6, 2026
Total Funding Raised
$1.6M
Momentum Score
25 /100
Company Overview
GelSana Therapeutics, Inc. is a biomaterials company developing novel hydrogel wound dressings designed to reduce inflammation and provide sustained drug delivery for chronic wounds.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GelSana Therapeutics Comps
Public and private peers based on sector, stage, and business model.
GelSana Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Mar 6, 2026 | ||||
| Accelerator | Jun 5, 2025 | ||||
| Grant | Sep 5, 2024 | ||||
| Seed | Feb 19, 2024 | ||||
| Seed | Nov 30, 2023 | ||||
Seed | Apr 26, 2022 |
GelSana Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innosphere Ventures Fund | Seed |
| MedTech Innovator | Accelerator |
| NIH RADx | Grant |
| Advanced Industries Accelerator Program | Grant |
| Innosphere Ventures | Pre Seed |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| Mines Venture Fund | Seed |
GelSana Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GelSana Therapeutics's valuation, stock price, and market status.